Policy on support from industry
Support from industry is in form of unrestricted grants towards scientific and professional activities of the EACPT. In relation to support from industry for the EACPT, the rules as described in the EFPIA Code of Practice on Relationships between the Pharmaceutical Industry and Professional Organisations should be adhered to.
Income in financial year 2014
Industry 65.5%
Non-industry 34.5%
Largest single industry support from Almirall (21.8% of total net income).
Income in financial year 2015
Industry: 43.65%
Non-industry: 56.35%
Largest single industry support from Bayer Ag: (43.65% of income)
Financial Outcome Letter 2015
Income in financial year 2016
Non-Industry: 100%
Income in financial year 2017
Industry: 0%
Non-industry: 100%
Largest single industry support: none
Income in financial year 2018
Industry: 0%
Non-industry: 100%
Largest single industry support: none
Income in financial year 2019
Industry: 0%
Non-industry: 100%
Largest single industry support: none
Income in financial year 2020
Industry: 0%
Non-industry: 100%
Largest single industry support: none
Income in financial year 2021
Industry: 0%
Non-industry: 100%
Largest single industry support: none
EACPT’s only funding source in 2021 was membership fees
Income in financial year 2022
Industry: 0%
Non-industry: 100%
Largest single industry support: none
EACPT’s only funding source in 2022 was membership fees
Income in financial year 2023
Industry: 0%
Non-industry: 100%
Largest single industry support: none
EACPT’s only funding source in 2023 was membership fees